August 27, 2026 | Intelligent Commercialization, Pharma, healthcare
Pharma teams are under growing pressure to navigate launch complexity, identify risks earlier, and engage HCPs more effectively.

In our latest series of articles, our experts explore how Intelligent Commercialization™ is helping pharma teams turn insights into action across the lifecycle.
This content was provided by Inizio
Latest Content from Inizio
The benefits of understanding the patient journey are well documented in mature markets. But in emerging markets the patient journey is less understood. We recently presented a webinar hosted by…
The IBD syndicated market tracker is part of our large auto-immune portfolio
Living with Lupus (SLE) is a quantitative study conducted online amongst patients in the US and European markets. The report will consist of 30-minute face to face interviews with a…
A segmentation study comes with high visibility and high stakes across your marketing and sales organisations. Ensuring that a segmentation is actionable is a consistent issue, particularly when stakeholders with multiple…
An overview of the six most-commonly researched, largest pharma markets in Latin America
Immuno-oncology is the new frontier in cancer treatment. Using the body’s own immune system to treat cancer, new therapies are producing impressive survival benefits, with reduced side effects. Of these therapies,…
Our client was developing a portfolio of innovative treatments and was in the process of recruiting a sales force to support the promotion of this portfolio. Research was required to…
Pegasus, an Ashfield company, part of UDG Healthcare plc, last night scooped its fifth ‘consultancy’ award of the year at the PRCA Awards in London’s Park Lane where it secured…
Our latest Free Thinking white paper explores the legacy of the Affordable Care Act and the future for healthcare
Pegasus, an Ashfield company, part of UDG Healthcare plc, is delighted to have been crowned Specialist Consultancy of the Year at this week’s prestigious PR Week Awards. The accolade tops…
